ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jul 2, 2007 - ViaCell, Inc. (NASDAQ: VIAC) today announced that Marc D. Beer, President and Chief Executive Officer of ViaCell, will present an update on its business activities and product pipeline at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference on Tuesday, July 10, 2007 at 3:00 p.m. at the Mandarin Oriental Hotel in New York, NY. A live audio webcast of the presentation will be available on the Investor Information section of the ViaCell website at http://www.viacellinc.com. A replay of the presentation will be available for approximately three months after the webcast.

About ViaCell

ViaCell, Inc. is a biotechnology company dedicated to enabling the widespread application of human cells as medicine. The Company markets ViaCord(R), a product offering through which families can preserve their baby's umbilical cord blood at the time of birth for possible future medical use in treating over 40 diseases including certain blood cancers and genetic diseases. ViaCell also conducts research and development primarily to investigate other potential therapeutic uses of umbilical cord blood-derived stem cells and on technology for expanding populations of these cells. ViaCell's pipeline is focused in the areas of cancer, cardiac disease, diabetes and fertility. For more information about ViaCell, visit our website at http://www.viacellinc.com. ViaCell(R) and ViaCord(R) are registered trademarks of ViaCell, Inc.

Contact

ViaCell, Inc.
Justine E. Koenigsberg, 617-914-3494
Senior Director, Corporate Communications

Posted: July 2007

View comments

Hide
(web1)